Literature DB >> 9784069

The UL112/113 gene products of human cytomegalovirus which colocalize with viral DNA in infected cell nuclei are related to efficient viral DNA replication.

T Yamamoto1, S Suzuki, K Radsak, K Hirai.   

Abstract

The UL112/113 gene products of human cytomegalovirus (HCMV) were shown by transient complementation ori Lyt-dependent DNA replication assay to be early viral proteins required for efficient viral DNA synthesis. By immunofluorescence analysis followed by fluorescence in situ hybridization, we showed that UL112/113 gene products of HCMV are colocalized with viral DNA prior to and during viral DNA replication in infected cell nuclei. We have used an anti-sense RNA approach for functional analysis of the UL112/113 gene in HCMV. The astrocytoma cell line U373-MG was used for permanent expression of the anti-sense UL112/113 gene. Expression of the anti-sense RNA in this cell line significantly blocked expression of UL112/113 gene products and viral DNA replication, indicating that the UL112/113 gene products are related to efficient viral DNA replication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784069     DOI: 10.1016/s0168-1702(98)00032-x

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  19 in total

1.  Role of the specific interaction of UL112-113 p84 with UL44 DNA polymerase processivity factor in promoting DNA replication of human cytomegalovirus.

Authors:  Young-Eui Kim; Jin-Hyun Ahn
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  Differential Requirement of Human Cytomegalovirus UL112-113 Protein Isoforms for Viral Replication.

Authors:  Tim Schommartz; Jiajia Tang; Rebekka Brost; Wolfram Brune
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  Interactions among four proteins encoded by the human cytomegalovirus UL112-113 region regulate their intranuclear targeting and the recruitment of UL44 to prereplication foci.

Authors:  Mi-Young Park; Young-Eui Kim; Myong-Rang Seo; Jae-Rin Lee; Chan Hee Lee; Jin-Hyun Ahn
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  The human cytomegalovirus UL112-113 locus can activate the full Kaposi's sarcoma-associated herpesvirus lytic replication cycle.

Authors:  Richard Wells; Laurence Stensland; Jeffrey Vieira
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 5.  DNA virus replication compartments.

Authors:  Melanie Schmid; Thomas Speiseder; Thomas Dobner; Ramon A Gonzalez
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

6.  Functional Dissection of an Alternatively Spliced Herpesvirus Gene by Splice Site Mutagenesis.

Authors:  Tim Schommartz; Stefan Loroch; Malik Alawi; Adam Grundhoff; Albert Sickmann; Wolfram Brune
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

7.  Intracellular Distribution of Capsid-Associated pUL77 of Human Cytomegalovirus and Interactions with Packaging Proteins and pUL93.

Authors:  Pánja Köppen-Rung; Alexandra Dittmer; Elke Bogner
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

8.  Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta.

Authors:  Takako Tabata; Matthew Petitt; Martin Zydek; June Fang-Hoover; Nicholas Larocque; Mitsuru Tsuge; Matthew Gormley; Lawrence M Kauvar; Lenore Pereira
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

9.  Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis.

Authors:  Ekaterina Maidji; Susan McDonagh; Olga Genbacev; Takako Tabata; Lenore Pereira
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

10.  Requirement of the N-terminal residues of human cytomegalovirus UL112-113 proteins for viral growth and oriLyt-dependent DNA replication.

Authors:  Young-Eui Kim; Mi Young Park; Kyeong Jin Kang; Tae Hee Han; Chan Hee Lee; Jin-Hyun Ahn
Journal:  J Microbiol       Date:  2015-07-31       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.